↓ Skip to main content

Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

Overview of attention for article published in Malaria Journal, February 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study
Published in
Malaria Journal, February 2009
DOI 10.1186/1475-2875-8-36
Pubmed ID
Authors

Peter Lackner, Andrea Part, Christoph Burger, Anelia Dietmann, Gregor Broessner, Raimund Helbok, Markus Reindl, Erich Schmutzhard, Ronny Beer

Abstract

Cerebral malaria (CM) is associated with high mortality and morbidity caused by a high rate of transient or persistent neurological sequelae. Studies on immunomodulatory and neuroprotective drugs as ancillary treatment in murine CM indicate promising potential. The current study was conducted to evaluate the efficacy of glatiramer acetate (GA), an immunomodulatory drug approved for the treatment of relapsing remitting multiple sclerosis, in preventing the death of C57Bl/6J mice infected with Plasmodium berghei ANKA.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 22%
Researcher 4 17%
Student > Ph. D. Student 4 17%
Student > Bachelor 2 9%
Student > Doctoral Student 1 4%
Other 3 13%
Unknown 4 17%
Readers by discipline Count As %
Medicine and Dentistry 6 26%
Agricultural and Biological Sciences 5 22%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Immunology and Microbiology 2 9%
Economics, Econometrics and Finance 1 4%
Other 2 9%
Unknown 5 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2015.
All research outputs
#6,203,234
of 19,102,792 outputs
Outputs from Malaria Journal
#2,110
of 5,049 outputs
Outputs of similar age
#94,206
of 305,828 outputs
Outputs of similar age from Malaria Journal
#1
of 1 outputs
Altmetric has tracked 19,102,792 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,049 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them